# Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial

> **NCT07636421** · PHASE4 · RECRUITING · sponsor: **Mansoura University** · enrollment: 332 (estimated)

## Conditions studied

- Postpartum Hemorrhage
- Uterine Atony
- Cesarean Section
- Blood Loss, Surgical

## Interventions

- **DRUG:** Carbetocin
- **DRUG:** Oxytocin
- **DRUG:** Placebo Saline Infusion

## Key facts

- **NCT ID:** NCT07636421
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-08
- **Primary completion:** 2028-04
- **Final completion:** 2028-08
- **Target enrollment:** 332 (ESTIMATED)
- **Last updated:** 2026-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07636421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07636421, "Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07636421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*